ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) CEO Stephen Davis

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) CEO Stephen Davis sold 11,427 shares of the company’s stock in a transaction on Thursday, May 2nd. The shares were sold at an average price of $16.94, for a total transaction of $193,573.38. Following the transaction, the chief executive officer now owns 155,231 shares of the company’s […]

Related Keywords

Alger , Algeria , Canada , Mizuho , Sakhalinskaya Oblast , Russia , United States , Robertw Baird , Stephen Davis , Pharmaceuticals Price Performance , Pharmaceuticals Company Profile , Pharmaceuticals Daily , Norges Bank , Eventide Asset Management , Acadia Pharmaceuticals Inc , Pharmaceuticals Inc , Mg Investment Management Ltd , Royal Bank , Fred Alger Management , Nasdaq , Get Free Report , Alger Management , Asset Management , Acadia Pharmaceuticals , Nasdaq Acad , Facad , Medical , Insider Trading , Nsider Trades , Stocks ,